These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7113112)

  • 21. Clinical assessment of preventing febrile nonhemolytic transfusion reaction by leukocyte-depleted blood transfusion.
    Zhao SM; Cheng XL; Hu J; Xiang GC; Zhang JS; Li RQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):568-70. PubMed ID: 12513724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets.
    Yazer MH; Raval JS; Triulzi DJ; Blumberg N
    Vox Sang; 2012 Feb; 102(2):175-7. PubMed ID: 21781126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the patients with recurrent acute transfusion reactions: A single tertiary medical centre experience.
    Hsieh MY; Chen JS; Yin CH
    J Int Med Res; 2023 Jul; 51(7):3000605231181733. PubMed ID: 37421139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of buffy coat reduction on the severity of febrile nonhemolytic transfusion reactions with red cell components.
    Singh L; Prinja N; Jain A; Sharma RR; Marwaha N
    Asian J Transfus Sci; 2023; 17(1):69-73. PubMed ID: 37188007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of leukocyte depletion of packed red blood cell units and impact on clinically observed transfusion reactions.
    Steblaj B; Galli J; Torgerson P; Kutter A
    Front Vet Sci; 2023; 10():1217575. PubMed ID: 37841457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Removal of white cells from red cells by transfusion through a new filter.
    Sirchia G; Wenz B; Rebulla P; Parravicini A; Carnelli V; Bertolini F
    Transfusion; 1990 Jan; 30(1):30-3. PubMed ID: 2296786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
    Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
    Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine release in febrile non-haemolytic red cell transfusion reactions.
    Lin JS; Tzeng CH; Hao TC; Hu HY; Ho YT; Lyou JY; Liu JM; Ho CH; Yung CH
    Vox Sang; 2002 Apr; 82(3):156-60. PubMed ID: 11952991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Febrile nonhemolytic transfusion reactions. Management by premedication and cost implications in adult patients.
    Ezidiegwu CN; Lauenstein KJ; Rosales LG; Kelly KC; Henry JB
    Arch Pathol Lab Med; 2004 Sep; 128(9):991-5. PubMed ID: 15335265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactions.
    Tsantes AE; Kyriakou E; Nikolopoulos GK; Stylos D; Sidhom M; Bonovas S; Douramani P; Kalantzis D; Kokoris S; Valsami S; Stamoulis K; Politou M; Foudoulaki-Paparizos L
    Blood Transfus; 2014 Apr; 12(2):232-7. PubMed ID: 24931843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of febrile nonhemolytic transfusion reactions.
    Heddle NM
    Curr Opin Hematol; 1999 Nov; 6(6):420-6. PubMed ID: 10546797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal mortality following transfusion of red cells with high plasma potassium levels.
    Hall TL; Barnes A; Miller JR; Bethencourt DM; Nestor L
    Transfusion; 1993 Jul; 33(7):606-9. PubMed ID: 8333025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte-depleted blood: a comparison of available preparations.
    Rock G; Baxter A; Gray E
    Can Med Assoc J; 1984 Jun; 130(12):1566-8. PubMed ID: 6733630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study on the use of leucocyte-filters in reducing blood transfusion reactions in multi-transfused thalassemic children.
    Tan KK; Lee WS; Liaw LC; Oh A
    Singapore Med J; 1993 Apr; 34(2):109-11. PubMed ID: 8266145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.
    Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC
    Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions.
    Heddle NM; Klama LN; Griffith L; Roberts R; Shukla G; Kelton JG
    Transfusion; 1993 Oct; 33(10):794-7. PubMed ID: 8236418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of microaggregate filtration in the prevention of febrile transfusion reactions.
    Schned AR; Silver H
    Transfusion; 1981; 21(6):675-81. PubMed ID: 7314215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of uncrossmatched type-O red cells for resuscitation from hemorrhagic shock.
    Dutton RP; Shih D; Edelman BB; Hess J; Scalea TM
    J Trauma; 2005 Dec; 59(6):1445-9. PubMed ID: 16394920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood transfusion reactions.
    Shafer N; Wilkenfeld M; Shafer R
    Leg Med; 1980; ():207-20. PubMed ID: 7421388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.